We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
–
AUM
$7.12B
AUM Growth
+$672M
Cap. Flow
+$202M
Cap. Flow %
2.84%
Top 10 Hldgs %
30.81%
Holding
2,906
New
717
Increased
1,154
Reduced
469
Closed
172

Top Buys

Rank Stock Value
1
USHY icon
iShares Broad USD High Yield Corporate Bond ETF
USHY
+$22M
2
VMBS icon
Vanguard Mortgage-Backed Securities ETF
VMBS
+$15.8M
3
NOW icon
ServiceNow
NOW
+$15.2M
4
LLY icon
Eli Lilly
LLY
+$11.8M
5
SMCI icon
Super Micro Computer
SMCI
+$11.5M

Top Sells

Rank Stock Value
1
IEI icon
iShares 3-7 Year Treasury Bond ETF
IEI
+$21.3M
2
HON icon
Honeywell
HON
+$11.2M
3
P
Everpure Inc
P
+$9.65M
4
SNPS icon
Synopsys
SNPS
+$8.66M
5
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$8.3M

Sector Composition

Rank Sector Weight
1 Technology 11.84%
2 Financials 7.35%
3 Industrials 4.85%
4 Consumer Discretionary 3.55%
5 Healthcare 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRSP
2651
BrightSpire Capital
BRSP
$681M
$66 ﹤0.01%
+13
New +$66
TMC icon
2652
TMC The Metals Company
TMC
$1.59B
$66 ﹤0.01%
+10
New +$38
ATNI icon
2653
ATN International
ATNI
$361M
$65 ﹤0.01%
+4
New +$65
HG icon
2654
Hamilton Insurance Group
HG
$3.59B
$65 ﹤0.01%
+3
New +$60
ISPR icon
2655
Ispire Technology
ISPR
$89M
$62 ﹤0.01%
+24
New +$67
LXFR icon
2656
Luxfer Holdings
LXFR
$460M
$61 ﹤0.01%
+5
New +$56
ATOS icon
2657
Atossa Therapeutics
ATOS
$22.8M
$59 ﹤0.01%
5
– –
CTGO icon
2658
Contango Silver & Gold Inc
CTGO
$529M
$59 ﹤0.01%
+3
New +$48
OI icon
2659
O-I Glass
OI
$1.39B
$59 ﹤0.01%
+4
New +$51
TMCI icon
2660
Treace Medical Concepts
TMCI
$259M
$59 ﹤0.01%
+10
New +$65
AIP icon
2661
Arteris
AIP
$1.4B
$58 ﹤0.01%
+6
New +$44
SITC icon
2662
SITE Centers
SITC
$230M
$57 ﹤0.01%
+5
New +$60
EDIT icon
2663
Editas Medicine
EDIT
$399M
$55 ﹤0.01%
25
– –
TNYA icon
2664
Tenaya Therapeutics
TNYA
$168M
$51 ﹤0.01%
+82
New +$42
XBIT icon
2665
XBiotech
XBIT
$69.2M
$51 ﹤0.01%
+17
New +$49
SKYE icon
2666
Skye Bioscience
SKYE
$22.9M
$51 ﹤0.01%
+12
New +$25
AMPL icon
2667
Amplitude
AMPL
$1.07B
$50 ﹤0.01%
+4
New +$43
CHCT
2668
Community Healthcare Trust
CHCT
$537M
$50 ﹤0.01%
+3
New +$49
RGNX icon
2669
Regenxbio
RGNX
$623M
$50 ﹤0.01%
+6
New +$50
CHMG icon
2670
Chemung Financial Corp
CHMG
$390M
$49 ﹤0.01%
+1
New +$46
VVX icon
2671
V2X
VVX
$2.62B
$49 ﹤0.01%
+1
New +$48
JELD icon
2672
JELD-WEN Holding
JELD
$94.8M
$48 ﹤0.01%
+12
New +$53
MFA
2673
MFA Financial
MFA
$929M
$48 ﹤0.01%
+5
New +$47
UNTY icon
2674
Unity Bancorp
UNTY
$583M
$48 ﹤0.01%
+1
New +$43
ADPT icon
2675
Adaptive Biotechnologies
ADPT
$3.56B
$47 ﹤0.01%
+4
New +$36
105 106
107
108 109

Similar funds

HTC
Haverford Trust Company Radnor, Pennsylvania $10.9B AUM 18.64% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BMSSC
B. Metzler seel. Sohn & Co Frankfurt, Germany $10.8B AUM 21.99% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

Clearstead Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Clearstead Advisors held 2,906 positions worth $7.12B, up 10% from $6.45B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Clearstead Advisors's Q2 2025 filing shows 717 new, 1,154 increased, 469 reduced and 172 closed positions. Its largest new stake was Vanguard Intermediate-Term Tax-Exempt Bond ETF: 9,578 shares worth $944K. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $21.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Clearstead Advisors's largest Q2 2025 buy was Vanguard Intermediate-Term Tax-Exempt Bond ETF: 9,578 shares worth $944K.
  • Clearstead Advisors added most to iShares Broad USD High Yield Corporate Bond ETF in Q2 2025, an estimated $22M increase.
  • Clearstead Advisors's biggest Q2 2025 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $21.3M.
  • Clearstead Advisors fully exited Invesco Senior Loan ETF in Q2 2025, selling an estimated $7.86M.
  • Clearstead Advisors's ten largest holdings make up 31% of its $7.12B portfolio in Q2 2025.
  • Clearstead Advisors opened 717 new positions and closed 172 in Q2 2025.
  • Clearstead Advisors's portfolio value rose 10% quarter-over-quarter to $7.12B.

Based on Clearstead Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.